TuesdaySep 29, 2020 1:28 pm

Predictive Oncology Inc. (NASDAQ: POAI) Set to Capitalize on Increased AI Usage within Oncological Treatments

Predictive Oncology develops AI-solutions designed to assist clinicians in formulating personalized treatment plans for oncological patients Artificial Intelligence is being increasingly used to help understand and accurately predict how drug therapies can interact with specific patients POAI’s TumorGenesis subsidiary is also creating laboratory-grown tumors to help clinicians and researchers to better test therapies Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, is set to play a key role as the integration of AI technology within cancer care continues to improve the accuracy and…

Continue Reading

TuesdaySep 29, 2020 12:36 pm

CNS Pharmaceuticals, Inc. (CNSP) Expands Scientific Advisory Board with Leading Neuro-Oncology Expert, Dr. Patrick Wen, M.D.

Pivotal Phase 2 Berubicin trial expected to commence in Q1 2021 following planned IND submission in Q4 2020 CNS Pharmaceuticals also plans to begin pre-clinical work on Berubicin in connection with treatment for lymphomas, pancreatic, and ovarian cancers Brain tumor drug therapeutics market expected to reach $3.4 billion by 2025 CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has expanded its Scientific Advisory Board by welcoming new member Dr. Patrick Wen, M.D., a leading neurology and neuro-oncology expert (https://ibn.fm/VJ6e9). Dr. Wen joins current Board members,…

Continue Reading

TuesdaySep 29, 2020 11:07 am

SRAX Inc. (NASDAQ: SRAX) Acquires LD Micro, Accelerates Adoption of SaaS Data Management Platform

SRAX recently closed acquisition of LD Micro, leading micro-cap information portal LD Micro to become wholly-owned subsidiary of SRAX for 1.6 million in common stock plus $4 million cash Acquisition to accelerate adoption of Sequire, SRAX’s SaaS investment analytics platform Sequire revenue grew 29% year-over-year for Q2 2020, user base doubled to one million users during Q3 2020 SRAX (NASDAQ: SRAX), a data-based financial technology company, recently closed the acquisition of LD Micro, a leading data portal serving the small and micro-cap space. The deal, worth 1,600,000 shares of common stock and $4 million in cash, will make LD Micro…

Continue Reading

MondaySep 28, 2020 2:06 pm

Mobius Interactive Ltd., AffPapa Announce Collaboration to Facilitate Process of Finding Partners, Overcome Challenges

Partnership allows space for significant exposure, growth over critical launch period AffPapa’s dedication to mission provides opportunities to broaden operator base, offer best services Mobius has already entered iGaming, eSports sectors with three differentiated brand offerings and hundreds of joint ventures with VIP and Master gaming affiliates Mobius Interactive has announced a new partnership with AffPapa, a unique platform that allows operators and affiliates to find each other. In a recent announcement, Mobius and AffPapa noted the “well-timed collaboration” designed to ease the process of finding partners and overcome challenges (https://ibn.fm/AYlFm). “By joining our affiliate site with the AffPapa global affiliate and operator partnership platform, MobiusAffiliates.com will be…

Continue Reading

MondaySep 28, 2020 12:49 pm

Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU) Awarded Funds by DOE to Develop Design for REE Production

Company awarded government grant that could total $1.45 million to develop design for production of rare earth elements UUUU excited to play role in effort to develop domestic sources of rare earth production Energy Fuels announced entry into REE sector earlier this year, ideal complement to company’s other rare earth initiatives Energy Fuels (TSX: EFR) (NYSE American: UUUU), a leading producer of uranium in the United States, along with a team from Penn State University has been awarded a government grant for an initial amount of $150,000 to develop a design for the production of rare earth elements (“REE”) from coal-based…

Continue Reading

MondaySep 28, 2020 12:18 pm

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Reports on Drilling Program at Virtual Investor Conference

BFGC lays out road map to success Potential of area highlighted as majors show interest Drill results encourage further exploration Gold price maintains lofty levels The virtual investor presentation given by Bullfrog Gold (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) at the Aug. 6 OTCQB Virtual Investor Conference laid out BFGC’s well-thought-out road map to becoming a profitable gold producer. Bullfrog was one of several companies carefully selected to present to individual and institutional investors, advisors and analysts attending the event. Starting with a brief account of BFGC’s earliest acquisitions, CEO David Beling went on to show the exciting potential the…

Continue Reading

MondaySep 28, 2020 10:57 am

Amid Surging OTT Market, The Movie Studio Inc. (MVES) Eyes Sunny Skies Thanks to Florida Location, Strategic Business Plan

Surging viewership numbers on online streaming platforms, capacity constraints amongst legacy film studios have led to increased need for new facilities A number of new film studios have recently been commissioned, including ones in Montana and Long Island The Movie Studio is only major independent film studio in South Florida, placing it in ideal position to benefit from surge in demand for original content production The Movie Studio (OTC: MVES), an independent Florida-based film studio, is set to benefit as a surge in demand for movie and television content has led to an increased need for film studios. With COVID…

Continue Reading

FridaySep 25, 2020 1:14 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, a novel DNA binding agent, was 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Industry reports estimate that the global brain…

Continue Reading

FridaySep 25, 2020 12:35 pm

Pac Roots Cannabis Corp. (CSE: PACR) Leverages Expertise, Resources to Establish Dominant Position in Growing Cannabis Market

Legal marijuana market set to top more than $90 billion by 2027 Pac Roots places top priority on developing, delivering finest cannabis genetics Optimized farming systems employed in most fertile areas means maximum opportunity for harvest After experiencing a few roadblocks over the last year, the cannabis sector looks to be picking up speed. In fact, a recent Data Bridge Market Research study reports that the global legal marijuana market should top more than $90 billion by 2027 (https://ibn.fm/UE8Tj). Pac Roots Cannabis (CSE: PACR), a Canadian company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, has taken…

Continue Reading

FridaySep 25, 2020 11:48 am

180 Life Sciences Corp. Leading Research into Novel Drug Therapies Expected to Produce First Results of Phase 2b/3 Trial in 2021

Anti-inflammatory therapeutics market to generate revenues of $191.42 billion through 2027 Novel drug therapy for Fibrosis and Anti-TNF trials being conducted by Professor Sir Marc Feldmann, who already developed one of the most commonly used anti-TNF medications, Remicade The number of conditions with chronic inflammation is expected to increase persistently over the next 30 years in the United States. 180 Life Sciences is in the process of being acquired by KBLM Merger Corp. and the acquisition is expected to finalize in Q4 2020 Clinical-stage biotechnology company 180 Life Sciences Corp. is leading the way with research into the world’s most…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered